tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrew Fein, 33 are a HOLD (3.95%), 803 are a BUY (96.05%).
Analyst Andrew Fein, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 48.43% that have a potential upside of 56.45% achieved within 250 days.
Andrew Fein’s has documented 1,558 price targets and ratings displayed on 85 stocks. The coverage is on Healthcare, Industrials, Technology, Energy sectors.
Most recent stock forecast was given on AMLX, Amylyx Pharmaceuticals at 18-Aug-2026.
Analyst best performing recommendations are on CCCC (C4 THERAPEUTICS).
The best stock recommendation documented was for INSM (INSMED) at 5/14/2024. The price target of $52 was fulfilled within 15 days with a profit of $26.55 (104.32%) receiving and performance score of 69.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Dec-2025
$33
$12.32 (59.57%)
$37
6 days ago
(24-Sep-2026)
0/3 (0%)
$12.32 (59.57%)
Buy Since 16-Apr-2025
$34
$13.32 (64.41%)
$36
6 days ago
(24-Sep-2026)
4/6 (66.67%)
$13.32 (64.41%)
144
Buy Since 25-Nov-2019
$33
$12.32 (59.57%)
$36
6 days ago
(24-Sep-2026)
9/25 (36%)
$12.32 (59.57%)
238
Buy Since 24-Sep-2025
$31
$10.32 (49.90%)
$38
6 days ago
(24-Sep-2026)
2/6 (33.33%)
$10.32 (49.90%)
574
Buy Since 27-Feb-2024
$35
$14.32 (69.25%)
$41
6 days ago
(24-Sep-2026)
9/15 (60%)
$14.32 (69.25%)
393
Which stock is Andrew Fein most bullish on?
Which stock is Andrew Fein most reserved on?
What Year was the first public recommendation made by Andrew Fein?
